Vildagliptin reversed diabetes-induced decrease of p-Akt, p-GSK-3β, brain-derived neurotrophic factor and nerve growth factor, thus against cognitive deficits and memory impairment [20]. This evidence concerns the gene GSK3B and diabetes mellitus.